Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias
Background Alzheimer's disease and related dementias (ADRD) affect over 55 million
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias.
B Idnay, J Liu, Y Fang, A Hernandez, S Kaw… - Journal of the …, 2024 - europepmc.org
Background Alzheimer's disease and related dementias (ADRD) affect over 55 million
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias
B Idnay, J Liu, Y Fang, A Hernandez… - Journal of the …, 2024 - academic.oup.com
Background Alzheimer's disease and related dementias (ADRD) affect over 55 million
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias
B Idnay, J Liu, Y Fang, A Hernandez… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Alzheimer's disease and related dementias (ADRD) affect over 55 million
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …
globally. Current clinical trials suffer from low recruitment rates, a challenge potentially …